D-Nav Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Liquidation

D-Nav General Information

Description

Developer of a diabetes insulin guidance system designed to autonomously adjust insulin doses directly to the patient. The company's technology automatically interprets patient data and independently initiates insulin management that helps people with type 2 diabetes adjust their insulin doses according to their body's changing insulin needs, enabling patients to monitor their diabetes levels digitally and maximize insulin effectiveness resulting in improved glycemic control.

Contact Information

Website
www.d-nav.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 24 Frank Lloyd Wright Drive
  • Suite L-4000
  • Ann Arbor, MI 48105
  • United States
+1 (734)
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Corporate Office
  • 24 Frank Lloyd Wright Drive
  • Suite L-4000
  • Ann Arbor, MI 48105
  • United States
+1 (734)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D-Nav Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 04-Nov-2024 Completed Bankruptcy: Liquidation
10. Later Stage VC (Series B) 03-May-2023 Completed Generating Revenue
9. Later Stage VC 26-Jan-2021 Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Debt - General 28-Sep-2020 Completed Generating Revenue
6. Debt - PPP 13-Apr-2020 Completed Generating Revenue
5. Later Stage VC 18-Nov-2019 Completed Generating Revenue
4. Later Stage VC (Series A) 13-Feb-2017 Completed Generating Revenue
3. Later Stage VC 13-Dec-2013 $1.52M $4.18M Completed Generating Revenue
2. Seed Round 12-Aug-2011 $2.66M $2.66M Completed Generating Revenue
To view D-Nav’s complete valuation and funding history, request access »

D-Nav Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series B-3
Series B-2
Series B-1 3,412,912 $0.000010 8% $0.32 $0.32 1x $0.32 2.68%
Series A 8,658,778 $0.000010 8% $0.63 $0.63 1x $0.54 7.96%
To view D-Nav’s complete cap table history, request access »

D-Nav Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diabetes insulin guidance system designed to autonomously adjust insulin doses directly to the patient. T
Clinics/Outpatient Services
Ann Arbor, MI
52 As of 2023

Denver, CO
 

Rotterdam, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

D-Nav Competitors (6)

One of D-Nav’s 6 competitors is Virta Health, a Venture Capital-Backed company based in Denver, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Virta Health Venture Capital-Backed Denver, CO
Diabeter Corporate Backed or Acquired Rotterdam, Netherlands
Canary Health Formerly VC-backed Los Angeles, CA
Glytec Venture Capital-Backed Atlanta, GA
Lark Venture Capital-Backed Mountain View, CA
To view D-Nav’s complete competitors history, request access »

D-Nav Patents

D-Nav Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023250076-A1 Systems and methods for identifying medical conditions or treatment issues using optimized diabetes patient management data Inactive 23-Jun-2022
EP-3030140-B1 Systems and devices for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
EP-3030140-A2 Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
EP-3030140-A4 Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Active 05-Aug-2013
WO-2015021041-A2 Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus Inactive 05-Aug-2013 A61B5/14532
To view D-Nav’s complete patent history, request access »

D-Nav Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

D-Nav FAQs

  • When was D-Nav founded?

    D-Nav was founded in 2008.

  • Where is D-Nav headquartered?

    D-Nav is headquartered in Ann Arbor, MI.

  • What is the size of D-Nav?

    D-Nav has 52 total employees.

  • What industry is D-Nav in?

    D-Nav’s primary industry is Clinics/Outpatient Services.

  • Is D-Nav a private or public company?

    D-Nav is a Private company.

  • What is D-Nav’s current revenue?

    The current revenue for D-Nav is .

  • How much funding has D-Nav raised over time?

    D-Nav has raised $34.2M.

  • Who are D-Nav’s competitors?

    Virta Health, Diabeter, Canary Health, Glytec, and Lark are some of the 6 competitors of D-Nav.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process